Thrombolytic compositions
US5202121A · kind A · utility
4Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 29, 1989 |
| Grant date | Apr 13, 1993 |
| Priority date | — |
| Expiry date | Dec 29, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P7/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A thrombolytically active composition comprising in combination a modified tissue-type plasminogen activator (t-PA) as a major component and a normal human t-PA, Streptokinase or human urokinase as a minor component in a pharmaceutically acceptable excipient; PA1 a method of treating a thrombotic disorder; and PA1 a medicinal kit or package for use in treating thrombotic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.